12.79
+0.79
+(6.58%)
At close: February 18 at 4:00:00 PM EST
Breakdown
12/31/2023
12/31/2022
Total Assets
71,504.00
149,957.00
Total Liabilities Net Minority Interest
445,352.00
432,416.00
Total Equity Gross Minority Interest
-373,848.00
-282,459.00
Total Capitalization
-353,768.00
-282,459.00
Common Stock Equity
-373,848.00
-282,459.00
Capital Lease Obligations
29,543.00
32,055.00
Net Tangible Assets
-373,848.00
-282,459.00
Working Capital
17,794.00
85,366.00
Invested Capital
-353,768.00
-282,459.00
Tangible Book Value
-373,848.00
-282,459.00
Total Debt
49,623.00
32,055.00
12/31/2022 - 1/31/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MTSR Metsera, Inc.
32.08
+4.91%
SION Sionna Therapeutics, Inc.
20.04
+0.05%
ALMS Alumis Inc.
5.06
-2.88%
SEPN Septerna, Inc.
6.87
-46.99%
AARD Aardvark Therapeutics, Inc. Common Stock
13.56
+1.95%
AAPG Ascentage Pharma Group Internat
18.51
+1.48%
BCAX Bicara Therapeutics Inc.
13.09
-2.89%
UPB Upstream Bio, Inc.
8.40
+10.53%
RAPP Rapport Therapeutics, Inc.
14.04
-11.70%
MBX MBX Biosciences, Inc.
10.90
+4.71%